EA200900095A1 - Лекарственные формы бифосфонатов для ингаляции и способы их применения - Google Patents
Лекарственные формы бифосфонатов для ингаляции и способы их примененияInfo
- Publication number
- EA200900095A1 EA200900095A1 EA200900095A EA200900095A EA200900095A1 EA 200900095 A1 EA200900095 A1 EA 200900095A1 EA 200900095 A EA200900095 A EA 200900095A EA 200900095 A EA200900095 A EA 200900095A EA 200900095 A1 EA200900095 A1 EA 200900095A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- protective
- present
- inhalation
- biphosphonates
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title 1
- 239000003223 protective agent Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 229940122361 Bisphosphonate Drugs 0.000 abstract 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000004663 bisphosphonates Chemical class 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение предлагает способы введения в организм пациента эффективного количества бифосфонатного активного вещества легочным путем. Аспекты настоящего изобретения включают введение активного вещества в организм пациента в сочетании с одним или несколькими средствами защиты слизистой оболочки, причем средство защиты может включать одно или несколько средств, к которым относятся протекторный фермент, и/или протекторная аминокислота, и/или протекторный пептид. Предлагаются также ингаляционные композиции для применения при осуществлении способов в соответствии с вариантами осуществления изобретения. Способы и композиции в соответствии с вариантами осуществления настоящего изобретения находят применение для множества различных целей, в том числе (но не только) при лечении болезненных состояний, связанных с резорбцией костей.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86678706P | 2006-11-21 | 2006-11-21 | |
PCT/US2007/083742 WO2008063865A2 (en) | 2006-11-21 | 2007-11-06 | Biphosphonate inhalant formulations and methods for using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200900095A1 true EA200900095A1 (ru) | 2009-08-28 |
Family
ID=39430445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200900095A EA200900095A1 (ru) | 2006-11-21 | 2007-11-06 | Лекарственные формы бифосфонатов для ингаляции и способы их применения |
Country Status (16)
Country | Link |
---|---|
US (1) | US20080132471A1 (ru) |
EP (1) | EP2086330A4 (ru) |
JP (1) | JP2010510230A (ru) |
KR (1) | KR20090083326A (ru) |
CN (1) | CN101522032A (ru) |
AR (1) | AR064269A1 (ru) |
AU (1) | AU2007324044A1 (ru) |
BR (1) | BRPI0714776A2 (ru) |
CA (1) | CA2658834A1 (ru) |
CL (1) | CL2007003276A1 (ru) |
EA (1) | EA200900095A1 (ru) |
IL (1) | IL196644A0 (ru) |
MX (1) | MX2009001271A (ru) |
TW (1) | TW200835504A (ru) |
WO (1) | WO2008063865A2 (ru) |
ZA (1) | ZA200900603B (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009076480A2 (en) * | 2007-12-10 | 2009-06-18 | Synthetic Genomics, Inc. | Methylbutanol as an advanced biofuel |
US20100034752A1 (en) * | 2008-08-11 | 2010-02-11 | Toru Hibi | Inhalant formulations comprising a bisphosphonate and a pyrazolone derivative and methods for using the same |
KR20110079813A (ko) * | 2008-09-22 | 2011-07-08 | 아이시스 이노베이션 리미티드 | 이미다조〔1,2-α〕피리디닐 비스포스포네이트 |
CN105640924B (zh) * | 2016-01-18 | 2018-11-02 | 杭州旦杰医学科技有限公司 | 用于呼吸道给药的阿仑膦酸钠粉雾剂及其制备方法和用途 |
CN107375306A (zh) * | 2017-09-04 | 2017-11-24 | 杭州旦承医药科技有限公司 | 利塞膦酸钠的用途及粉雾剂和制备方法 |
CN107550919A (zh) * | 2017-09-04 | 2018-01-09 | 杭州旦承医药科技有限公司 | 唑来膦酸的用途及粉雾剂和制备方法 |
CN107441101A (zh) * | 2017-09-04 | 2017-12-08 | 杭州旦承医药科技有限公司 | 伊班膦酸钠的用途及粉雾剂和制备方法 |
CN111053761B (zh) * | 2020-01-16 | 2022-05-03 | 杭州旦承医药科技有限公司 | 一种吸入用双膦酸类药物及其制备方法及其在慢性阻塞性肺疾病的用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1201087B (it) * | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
US5183815A (en) * | 1991-01-22 | 1993-02-02 | Merck & Co., Inc. | Bone acting agents |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
ATE176476T1 (de) * | 1992-12-02 | 1999-02-15 | Hoechst Ag | Guanidinalkyl-1, 1-bisphosphonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung |
US5462932A (en) * | 1994-05-17 | 1995-10-31 | Merck & Co., Inc. | Oral liquid alendronate formulations |
US5906811A (en) * | 1997-06-27 | 1999-05-25 | Thione International, Inc. | Intra-oral antioxidant preparations |
US6015801A (en) * | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6414006B1 (en) * | 1998-10-15 | 2002-07-02 | Merck Frosst Canada & Co. | Methods for inhibiting bone resorption |
AU1525700A (en) * | 1998-11-19 | 2000-06-05 | Board Of Trustees Of The University Of Arkansas, The | Increasing bone strength with selected bisphosphonates |
US6482411B1 (en) * | 1999-08-27 | 2002-11-19 | Board Of Regents, The University Of Texas System | Methods of reducing bone loss with CD40 ligand |
ES2268086T3 (es) * | 2001-05-02 | 2007-03-16 | Novartis Ag | Metodo de administracion de bisfosfonatos por inhalacion en el tratamiento o prevencion de la resorcion osea y la osteoporosis. |
US20050008633A1 (en) * | 2003-05-19 | 2005-01-13 | Advanced Inhalation Research Inc. | Chemical and physical modulators of bioavailability of inhaled compositions |
-
2007
- 2007-11-06 AU AU2007324044A patent/AU2007324044A1/en not_active Abandoned
- 2007-11-06 ZA ZA200900603A patent/ZA200900603B/xx unknown
- 2007-11-06 BR BRPI0714776-7A patent/BRPI0714776A2/pt not_active IP Right Cessation
- 2007-11-06 MX MX2009001271A patent/MX2009001271A/es not_active Application Discontinuation
- 2007-11-06 EA EA200900095A patent/EA200900095A1/ru unknown
- 2007-11-06 WO PCT/US2007/083742 patent/WO2008063865A2/en active Application Filing
- 2007-11-06 JP JP2009537271A patent/JP2010510230A/ja active Pending
- 2007-11-06 KR KR1020097002024A patent/KR20090083326A/ko not_active Application Discontinuation
- 2007-11-06 CN CNA2007800364932A patent/CN101522032A/zh active Pending
- 2007-11-06 EP EP07844896A patent/EP2086330A4/en not_active Withdrawn
- 2007-11-06 CA CA002658834A patent/CA2658834A1/en not_active Abandoned
- 2007-11-06 US US11/935,764 patent/US20080132471A1/en not_active Abandoned
- 2007-11-14 CL CL200703276A patent/CL2007003276A1/es unknown
- 2007-11-15 TW TW096143138A patent/TW200835504A/zh unknown
- 2007-11-19 AR ARP070105128A patent/AR064269A1/es unknown
-
2009
- 2009-01-21 IL IL196644A patent/IL196644A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200900603B (en) | 2010-05-26 |
MX2009001271A (es) | 2009-02-11 |
CA2658834A1 (en) | 2008-05-29 |
AU2007324044A1 (en) | 2008-05-29 |
EP2086330A4 (en) | 2010-10-20 |
CL2007003276A1 (es) | 2008-05-30 |
CN101522032A (zh) | 2009-09-02 |
JP2010510230A (ja) | 2010-04-02 |
TW200835504A (en) | 2008-09-01 |
BRPI0714776A2 (pt) | 2013-07-16 |
IL196644A0 (en) | 2009-11-18 |
AR064269A1 (es) | 2009-03-25 |
EP2086330A2 (en) | 2009-08-12 |
WO2008063865A2 (en) | 2008-05-29 |
WO2008063865A3 (en) | 2008-10-16 |
KR20090083326A (ko) | 2009-08-03 |
US20080132471A1 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200900095A1 (ru) | Лекарственные формы бифосфонатов для ингаляции и способы их применения | |
ATE538774T1 (de) | Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen | |
EA200970287A1 (ru) | Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты | |
EA201100927A1 (ru) | Циклические аналоги 4-амино-4-оксобутаноил-пептидов, ингибиторы репликации вирусов | |
TR201900542T4 (tr) | Ağrı ve/veya enflamasyon tedavisi için bileşimler. | |
EA201270666A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
DK1885333T3 (da) | Farmaceutisk formulering af apomorphin til bukkal indgivelse | |
BR112014007675A2 (pt) | tratamento de doença articular degenerativa | |
EA201101525A1 (ru) | Фармацевтическая композиция | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
BR112014015482A8 (pt) | compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática | |
BR112013005673A2 (pt) | uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes | |
AR060089A1 (es) | Tratamiento del dolor | |
EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
BRPI0607536A2 (pt) | tratamento de dor | |
BR112014008036A2 (pt) | tratamento de rinite | |
CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
ECSP10010516A (es) | Uso de variantes de igf-i pegiladas para el tratamiento de trastornos neuromusculares | |
ATE555108T1 (de) | Polyamide zur behandlung des menschlichen papilloma-virus | |
EA200900881A1 (ru) | Ингаляционные лекарственные формы связанных с полимерами бифосфонатов и способы их применения | |
EP4218786A3 (en) | Opiorphin for use as analgesic agent | |
BR112013020195A2 (pt) | composições farmacêuticas livres de citrato compreendendo anakinra | |
EA201591095A1 (ru) | Белок slurp-1 для применения в лечении глазных болезней | |
RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных |